Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Liquid biopsy enters the clinic — implementation issues and future challenges
Michail Ignatiadis, George W. Sledge, Stefanie S. Jeffrey
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 5, pp. 297-312
Closed Access | Times Cited: 855

Showing 1-25 of 855 citing articles:

Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 454
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Philip J. Johnson, Qing Zhou, Doan Y Dao, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 10, pp. 670-681
Closed Access | Times Cited: 204
The Role of Artificial Intelligence in Early Cancer Diagnosis
Benjamin Hunter, Sumeet Hindocha, Richard W. Lee
Cancers (2022) Vol. 14, Iss. 6, pp. 1524-1524
Open Access | Times Cited: 186
Cancer evolution: Darwin and beyond
Roberto Vendramin, Kevin Litchfield, Charles Swanton
The EMBO Journal (2021) Vol. 40, Iss. 18
Open Access | Times Cited: 180
Biology, vulnerabilities and clinical applications of circulating tumour cells
Alexander Ring, Bich Doan Nguyen-Sträuli, Andreas Wicki, et al.
Nature reviews. Cancer (2022) Vol. 23, Iss. 2, pp. 95-111
Open Access | Times Cited: 168
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial
Andrea Sartore‐Bianchi, Filippo Pietrantonio, Sara Lonardi, et al.
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1612-1618
Open Access | Times Cited: 159
Proteomics technologies for cancer liquid biopsies
Zhiyong Ding, Nan Wang, Ning Ji, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 146
Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial
Yongxiang Xia, Weiwei Tang, Xiaofeng Qian, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 4, pp. e004656-e004656
Open Access | Times Cited: 136
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Yue Zhou, Lei Tao, Jiahao Qiu, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 126
Circulating cell-free DNA for cancer early detection
Qiang Gao, Qiang Zeng, Zhijie Wang, et al.
The Innovation (2022) Vol. 3, Iss. 4, pp. 100259-100259
Open Access | Times Cited: 120
Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer
Cameron Herberts, Matti Annala, Joonatan Sipola, et al.
Nature (2022) Vol. 608, Iss. 7921, pp. 199-208
Closed Access | Times Cited: 114
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Justin Jee, Emily S. Lebow, Randy Yeh, et al.
Nature Medicine (2022) Vol. 28, Iss. 11, pp. 2353-2363
Open Access | Times Cited: 109
Current and Future Clinical Applications of ctDNA in Immuno-Oncology
Julia-Christina Stadler, Yassine Belloum, Benjamin Deitert, et al.
Cancer Research (2021) Vol. 82, Iss. 3, pp. 349-358
Open Access | Times Cited: 107
Prognostic value of plasma circulating tumor DNA fraction across four common cancer types: a real-world outcomes study
Zachery R. Reichert, Todd M. Morgan, Gerald Li, et al.
Annals of Oncology (2022) Vol. 34, Iss. 1, pp. 111-120
Open Access | Times Cited: 100
Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future
Dilara Akhoundova, Mark A. Rubin
Cancer Cell (2022) Vol. 40, Iss. 9, pp. 920-938
Open Access | Times Cited: 91
Molecular Characterization of Exosomes for Subtype-Based Diagnosis of Breast Cancer
Ya Cao, Xiaomeng Yu, Tianyu Zeng, et al.
Journal of the American Chemical Society (2022) Vol. 144, Iss. 30, pp. 13475-13486
Closed Access | Times Cited: 88
Current advances in the use of exosomes, liposomes, and bioengineered hybrid nanovesicles in cancer detection and therapy
Anubhab Mukherjee, Bharti Bisht, Suman Dutta, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 11, pp. 2759-2776
Open Access | Times Cited: 83
Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints
Yida Huang, Shaoqian Du, Jun Liu, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 12
Open Access | Times Cited: 82
A clinician’s handbook for using ctDNA throughout the patient journey
Samantha O. Hasenleithner, Michael R. Speicher
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 82
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
Miguel García-Pardo, Maisam Makarem, Janice J.N. Li, et al.
British Journal of Cancer (2022) Vol. 127, Iss. 4, pp. 592-602
Open Access | Times Cited: 81
Systemic therapy for early-stage breast cancer: learning from the past to build the future
Elisa Agostinetto, Joseph Gligorov, Martine Piccart
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 763-774
Open Access | Times Cited: 81
Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer
Ellen Heitzer, Daan van den Broek, Marc G. Denis, et al.
ESMO Open (2022) Vol. 7, Iss. 2, pp. 100399-100399
Open Access | Times Cited: 78
Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives
Felice Crocetto, Gianluca Russo, Erika Di Zazzo, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3272-3272
Open Access | Times Cited: 74
Hepatitis Virus and Hepatocellular Carcinoma: Recent Advances
Chen Shen, Xin Jiang, Mei Li, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 533-533
Open Access | Times Cited: 74
DNA in extracellular vesicles: from evolution to its current application in health and disease
Jamal Ghanam, Venkatesh Kumar Chetty, Lennart Barthel, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 72
Page 1 - Next Page

Scroll to top